Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrice Andre

Showing results (11-20 of 141) with videos related to

Pageof 15
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Precision medicine for metastatic breast cancerElise Deluche, Elisa Onesti, Fabrice Andre
Breast Care (Basel, Switzerland)|August 2, 2013
Immunomodulation via Chemotherapy and Targeted Therapy: A New Paradigm in Breast Cancer Therapy?John Stagg, Fabrice Andre, Sherene Loi
Current Opinion in Oncology|October 8, 2013
Issues in clinical research for metastatic breast cancerSemih Dogan, Fabrice Andre, Monica Arnedos
Nature Reviews. Clinical Oncology|October 2, 2013
Reproducibility of research and preclinical validation: problems and solutionsLajos Pusztai, Christos Hatzis, Fabrice Andre
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
The horizon of precision medicine in breast cancer: fragmentation, alliance, or reunification?Fabrice Andre, Cecile Vicier, Suzette Delaloge
Bulletin Du Cancer|December 31, 2021
Ingrid Garberis, Fabrice Andre, Magali Lacroix-Triki
The Lancet. Oncology|March 5, 2013
What can be done for patients with NSCLC without druggable targets?Benjamin Besse, Fabrice Andre, Jean-Charles Soria
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
Biology-driven phase II trials: what is the optimal model for molecular selection?Fabrice Andre, Suzette Delaloge, Jean-Charles Soria
Current Opinion in Oncology|October 8, 2013
New strategies to overcome resistance to mammalian target of rapamycin inhibitors in breast cancerCecile Vicier, Maria V Dieci, Fabrice Andre
European Journal of Cancer (Oxford, England : 1990)|September 24, 2023
Placing the patient at the heart of discovery scienceMihaela Aldea, Elsa Bernard, Charles Swanton, et al.
Pageof 15

Showing results (11-20 of 141) with videos related to

Sort By:
Pageof 15
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Precision medicine for metastatic breast cancerElise Deluche, Elisa Onesti, Fabrice Andre
Breast Care (Basel, Switzerland)|August 2, 2013
Immunomodulation via Chemotherapy and Targeted Therapy: A New Paradigm in Breast Cancer Therapy?John Stagg, Fabrice Andre, Sherene Loi
Current Opinion in Oncology|October 8, 2013
Issues in clinical research for metastatic breast cancerSemih Dogan, Fabrice Andre, Monica Arnedos
Nature Reviews. Clinical Oncology|October 2, 2013
Reproducibility of research and preclinical validation: problems and solutionsLajos Pusztai, Christos Hatzis, Fabrice Andre
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
The horizon of precision medicine in breast cancer: fragmentation, alliance, or reunification?Fabrice Andre, Cecile Vicier, Suzette Delaloge
Bulletin Du Cancer|December 31, 2021
Ingrid Garberis, Fabrice Andre, Magali Lacroix-Triki
The Lancet. Oncology|March 5, 2013
What can be done for patients with NSCLC without druggable targets?Benjamin Besse, Fabrice Andre, Jean-Charles Soria
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
Biology-driven phase II trials: what is the optimal model for molecular selection?Fabrice Andre, Suzette Delaloge, Jean-Charles Soria
Current Opinion in Oncology|October 8, 2013
New strategies to overcome resistance to mammalian target of rapamycin inhibitors in breast cancerCecile Vicier, Maria V Dieci, Fabrice Andre
European Journal of Cancer (Oxford, England : 1990)|September 24, 2023
Placing the patient at the heart of discovery scienceMihaela Aldea, Elsa Bernard, Charles Swanton, et al.
Pageof 15